. 2018 Oct 10;2(20):2581–2587. doi: 10.1182/bloodadvances.2018024562

Table 1.

Characteristics of unexposed RBCs and dRBCs

Sample	Hb, g/dL	MCHC, g/dL	Diameter, µm	MCV, µm³	Projected area, µm²	S/V, µm⁻¹	Sphericity	Relative rigidity	Retention rate, %
Sample	Hb, g/dL	MCHC, g/dL	Diameter, µm	MCV, µm³	Projected area, µm²	S/V, µm⁻¹	Sphericity	Relative rigidity	Spleen	Microsphilters
Untreated RBCs	11.3 (1.3)	34 (2)	9.2 (0.003)	92 (2)	67 (0.01)	0.73 (0.02)	0.82 (0.01)	1.0 (0.2)	9 (5)	0 (0)
Diamide-treated RBCs
10-60 µM	11.8 (1.9)	34 (2)	9.4 (0.04)	91 (2)	70 (0.4)	0.77 (0.02)	0.82 (0.001)	1.3 (0.4)	24 (13)	2 (3)
75-250 µM	11.5 (1.6)	34 (1)	9.4 (0.1)	91 (4)	70 (2)	0.77 (0.04)	0.83 (0.01)	4.1 (1.7)	41 (5)	19 (16)
300-500 µM	11.4 (1.3)	33 (1)	9.5 (0.1)	95 (4)	72 (2)	0.76 (0.04)	0.83 (0.02)	17.4 (4.3)	58 (5)	13 (13)

Hemoglobin (Hb), MCHC, and mean cell volume (MCV) were measured with an ADVIA hematology system. Sphericity = aspect ratio. All data are mean (standard deviation).